Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls
- 1 November 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Rheumatology
- Vol. 22 (6), 633-638
- https://doi.org/10.1097/bor.0b013e32833f1970
Abstract
To present the latest findings regarding interstitial lung disease (ILD) in idiopathic inflammatory myopathies, focusing on the phenotype of ILD and auto-antibodies, pathogenesis and treatment. Interstitial lung disease is a common manifestation of myositis and different phenotypes of ILD associate with various clinical or serological phenotypes. Thus, antisynthetase antibodies are strongly associated with ILD, especially for non-Jo-1 (anti-PL-7 and anti-PL-12) where the association approaches 90-100%. A rare form of ILD with a very poor prognosis, acute and rapidly progressive lung disease, is strongly associated with clinically amyopathic dermatomyositis (CADM) and a novel - anti-CADM-140 auto-antibody. A combination of anti-Jo-1 and anti-SSA/Ro antibodies is another marker of severe pulmonary involvement. The use of immunossuppresive therapy in myositis-associated ILD is based on clinical experience, and a few new case reports indicate beneficial effect of tacrolimus in antisynthetase syndrome and rituximab in resistant or acute forms of lung disease but further studies are needed. Interstitial lung disease is a common manifestation of myositis. Auto-antibody profile seems to determine the frequency, course and severity of lung disease. New biological therapies such as rituximab show promising results in resistant and acute lung disease but controlled trials are needed.Keywords
This publication has 41 references indexed in Scilit:
- Sera from anti–Jo‐1–positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cellsArthritis & Rheumatism, 2009
- Interstitial lung disease in polymyositis and dermatomyositisClinical Rheumatology, 2009
- Autoantibodies and their significance in myositisCurrent Rheumatology Reports, 2008
- Interstitial lung disease in polymyositis and dermatomyositis: Longitudinal evaluation by pulmonary function and radiologyArthritis Care & Research, 2008
- Developments in the scientific and clinical understanding of inflammatory myopathiesArthritis Research & Therapy, 2008
- Novel conformation of histidyl–transfer RNA synthetase in the lungArthritis & Rheumatism, 2007
- In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtypeArthritis Research & Therapy, 2006
- Interstitial lung disease in polymyositis and dermatomyositisCurrent Opinion in Rheumatology, 2005
- Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patientsLupus, 2005
- Polymyositis, Pulmonary Fibrosis and Autoantibodies to Aminoacyl-tRNA Synthetase EnzymesQJM: An International Journal of Medicine, 1990